Affinity Asset Advisors, LLC
CIK 1773195 · Lihat di SEC EDGAR ↗
- Nilai Portofolio
- $2.2B
- Posisi
- 113
- Per tanggal
- 30 Juni 2026
#1.415 dari 9.443 berdasarkan nilai 13F · top 15.0%
Nilai portofolio QoQ: +14.3% 13F tidak mengungkapkan kas
- Bobot 10 kepemilikan teratas
- 39,41%
- Bobot 25 kepemilikan teratas
- 64,62%
- Posisi di atas 1%
- 31
- Jumlah posisi efektif
- 41,6
Berdasarkan kepemilikan ekuitas jangka panjang 13F saja (kas, obligasi, posisi jual tidak diungkapkan)
Perputaran Q2 2026: 24,36% Perkiraan pembelian $505.306.164 · penjualan $574.861.844
Kepemilikan median: 2,0 kuartal Dilacak Q4 2024–Q2 2026 · 48,1% masih dipegang
- Posisi baru
- 26
- Meningkat
- 33
- Menurun
- 30
- Tertutup
- 15
Eksposur put-notional: 2,5% put 13F melaporkan posisi opsi pada nilai notional yang mendasarinya — dapat mencakup lindung nilai, tidak selalu taruhan bearish
Di halaman ini
- Kinerja vs S&P Bagaimana portofolio 13F manajer ini berkinerja terhadap S&P 500.
- Rincian sektor Bagaimana portofolio terbagi di berbagai sektor pasar.
- Portofolio Setiap saham yang dilaporkan dimiliki oleh institusi ini, dari 13F terbarunya.
- Taruhan Bernilai Tinggi Kepemilikan yang paling terkonsentrasi pada manajer ini.
- Taruhan baru terbesar Posisi baru yang dibuka pada kuartal terakhir.
- Pergerakan Teratas Peningkatan dan penurunan posisi terbesar pada kuartal ini.
- Posisi yang keluar Posisi yang sepenuhnya dijual oleh manajer pada kuartal lalu.
Kinerja vs S&P 500
Tahunan: +63.7% · S&P 500: +18.0%
Perkiraan portofolio beli-dan-tahan yang dibangun dari snapshot 13F SEC triwulanan. Mengecualikan kas, posisi jual, opsi/derivatif, dan sekuritas non-13(f) — mencerminkan buku ekuitas long yang diungkapkan saja, bukan total AUM dana. Keterlambatan pengajuan SEC hingga 45 hari; ini bukan waktu yang dapat disalin secara real-time.
Cakupan yang dapat dihargai: 91,2% · Opsi dikecualikan: 16,8%
Rincian sektor
Healthcare
91,6%
N/A
0,1%
Lainnya/Tidak terpetakan
8,3%
Portofolio lengkap 113 posisi
| Tipe | Rentetan | Tren 8 kuartal | |||||
|---|---|---|---|---|---|---|---|
| ROIV Roivant Sciences Ltd. - Common Shares | $132.712.500 | 6,00% | 3.750.000 | $55.152.500 | Naik ×5 | ||
| APGE Apogee Therapeutics, Inc. - Common Stock | $131.004.510 | 5,92% | 987.000 | $22.852.289 | Turun ×1 | ||
| SYRE Spyre Therapeutics, Inc. - Common Stock | $113.561.517 | 5,13% | 1.279.134 | $49.041.998 | |||
| XENE Xenon Pharmaceuticals Inc. - Common Shares | $96.274.200 | 4,35% | 1.595.000 | $-1.127.050 | Turun ×1 | ||
| ERAS Erasca, Inc. - Common Stock | $96.180.000 | 4,35% | 5.250.000 | $9.617.000 | Turun ×1 | ||
| INSM Insmed Incorporated - Common Stock | $69.303.000 | 3,13% | 650.000 | $-9.186.600 | Naik ×2 | ||
| PRAX Praxis Precision Medicines, Inc. - Common Stock | $61.936.150 | 2,80% | 185.000 | $7.163.850 | Naik ×1 | ||
| ALKS Alkermes plc - Ordinary Shares | $58.944.375 | 2,66% | 1.125.000 | $11.208.375 | Turun ×1 | ||
| ORKA Oruka Therapeutics, Inc. - Common Stock | $56.150.300 | 2,54% | 590.000 | $31.641.339 | Naik ×1 | ||
| ANAB AnaptysBio, Inc. - Common Stock | $55.762.358 | 2,52% | 826.109 | $3.629.958 | Turun ×1 | ||
| AVTX Avalo Therapeutics, Inc. - Common Stock | $53.592.000 | 2,42% | 2.900.000 | $33.573.259 | Naik ×4 | ||
| CYTK Cytokinetics, Incorporated - Common Stock | $46.854.500 | 2,12% | 550.000 | $685.665 | Turun ×2 | ||
| RVMD Revolution Medicines, Inc. - Common Stock | $46.820.000 | 2,12% | 250.000 | $37.095.000 | Naik ×1 | ||
| ABVX Abivax SA - American Depositary Shares | $43.975.800 | 1,99% | 330.000 | $-1.120.950 | Turun ×2 | ||
| Penerbit tidak dikenal (CUSIP: 337185102) | $40.884.081 | 1,85% | 2.032.012 | Naik ×1 | |||
| DNTH Dianthus Therapeutics, Inc. - Common Stock | $38.992.000 | 1,76% | 400.000 | $9.620.000 | Naik ×2 | ||
| STRO Sutro Biopharma, Inc. - Common Stock | $38.926.568 | 1,76% | 1.172.487 | $12.284.850 | Naik ×2 | ||
| MRNA Moderna, Inc. - Common Stock | $35.015.000 | 1,58% | 500.000 | Opsi jual | Naik ×1 | ||
| NUVL Nuvalent, Inc. - Class A Common Stock | $33.962.500 | 1,54% | 275.000 | $3.227.500 | Turun ×5 | ||
| TRVI Trevi Therapeutics, Inc. - Common Stock | $33.573.208 | 1,52% | 1.800.172 | $9.711.156 | Turun ×3 | ||
| MRNA Moderna, Inc. - Common Stock | $33.264.250 | 1,50% | 475.000 | Opsi beli | $-7.375.750 | Turun ×1 | |
| ARKG | $31.545.000 | 1,43% | 750.000 | Opsi beli | Naik ×1 | ||
| OVID Ovid Therapeutics Inc. - Common Stock | $27.288.872 | 1,23% | 10.144.562 | $3.676.246 | Turun ×1 | ||
| LXEO Lexeo Therapeutics, Inc. - Common Stock | $27.034.429 | 1,22% | 5.807.611 | $-1.953.782 | Naik ×2 | ||
| CLDX Celldex Therapeutics, Inc. - Common Stock | $26.047.000 | 1,18% | 700.000 | $10.187.000 | Naik ×3 | ||
| BLTE Belite Bio, Inc - American Depositary Shares | $25.407.525 | 1,15% | 165.000 | $15.043.925 | Naik ×2 | ||
| ELVN Enliven Therapeutics, Inc. - Common Stock | $25.375.000 | 1,15% | 500.000 | $2.368.363 | Turun ×1 | ||
| FBRX Forte Biosciences, Inc. - Common Stock | $24.339.559 | 1,10% | 1.145.391 | $-1.868.392 | Naik ×2 | ||
| LLY Eli Lilly and Company Common Stock | $23.988.600 | 1,08% | 20.000 | Opsi beli | Naik ×1 | ||
| NRIX Nurix Therapeutics, Inc. - Common stock | $23.474.461 | 1,06% | 967.620 | $8.476.351 | |||
| ANRO Alto Neuroscience, Inc. Common Stock | $22.431.500 | 1,01% | 850.000 | $11.191.500 | Naik ×1 | ||
| MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | $21.478.000 | 0,97% | 40.000 | $-7.312.850 | Turun ×1 | ||
| PTGX Protagonist Therapeutics, Inc. - Common Stock | $21.099.083 | 0,95% | 172.125 | $2.957.108 | |||
| MLYS Mineralys Therapeutics, Inc. - Common Stock | $20.235.000 | 0,91% | 750.000 | $-82.500 | |||
| RLAY Relay Therapeutics, Inc. - Common Stock | $19.645.500 | 0,89% | 1.050.000 | $15.665.500 | Naik ×1 | ||
| SGMT Sagimet Biosciences Inc. - Series A Common Stock | $19.308.489 | 0,87% | 2.497.864 | $14.773.084 | Naik ×1 | ||
| JBIO Jade Biosciences, Inc. - Common Stock | $18.672.577 | 0,84% | 840.350 | $9.681.195 | Naik ×1 | ||
| COGT Cogent Biosciences, Inc. - Common Stock | $17.415.000 | 0,79% | 450.000 | $-11.452.500 | Turun ×1 | ||
| TVTX Travere Therapeutics, Inc. - Common Stock | $17.043.000 | 0,77% | 300.000 | $8.130.000 | |||
| CGEM Cullinan Therapeutics, Inc. - Common Stock | $15.947.590 | 0,72% | 875.760 | $4.845.885 | Naik ×1 | ||
| SVRA Savara, Inc. - Common Stock | $15.474.862 | 0,70% | 2.512.153 | $1.758.507 | |||
| IDYA IDEAYA Biosciences, Inc. - Common Stock | $14.908.000 | 0,67% | 400.000 | Naik ×1 | |||
| CATX | $14.371.725 | 0,65% | 4.214.582 | $1.175.418 | Naik ×2 | ||
| Penerbit tidak dikenal (CUSIP: 67613T104) | $14.338.334 | 0,65% | 766.346 | Naik ×1 | |||
| Penerbit tidak dikenal (CUSIP: 19240QAA0) | $13.653.740 | 0,62% | 11.000.000 | $5.068.240 | Naik ×2 | ||
| OMER Omeros Corporation - Common Stock | $13.421.463 | 0,61% | 1.411.300 | Opsi jual | |||
| HLXC Helix Acquisition Corp. III - Class A Ordinary Shares | $13.300.000 | 0,60% | 1.250.000 | $600.000 | |||
| EQ Equillium, Inc. - Common Stock | $13.120.000 | 0,59% | 4.100.000 | $10.667.380 | Naik ×1 | ||
| ALKS Alkermes plc - Ordinary Shares | $13.098.750 | 0,59% | 250.000 | Opsi beli | Naik ×1 | ||
| ESTA Establishment Labs Holdings Inc. - Common Shares | $12.700.996 | 0,57% | 148.013 | $7.022.996 | Naik ×1 | ||
| CLYM Climb Bio, Inc. - Common Stock | $12.674.880 | 0,57% | 972.000 | $7.879.880 | Naik ×1 | ||
| TEVA Teva Pharmaceutical Industries Limited American Depositary Shares | $12.671.120 | 0,57% | 374.000 | $-29.496.880 | Turun ×1 | ||
| MANE Veradermics, Incorporated Common Stock | $12.294.000 | 0,56% | 100.000 | $7.873.500 | Naik ×1 | ||
| ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | $12.226.500 | 0,55% | 150.000 | $-313.500 | Turun ×1 | ||
| Penerbit tidak dikenal (CUSIP: 682143AK8) | $12.182.372 | 0,55% | 6.525.000 | $-1.036.854 | |||
| TSHA Taysha Gene Therapies, Inc. - Common Stock | $11.917.500 | 0,54% | 1.750.000 | $7.447.500 | Naik ×1 | ||
| GLTO Galecto, Inc. - Common Stock | $11.054.250 | 0,50% | 425.000 | $-600.750 | Turun ×1 | ||
| EPRX Eupraxia Pharmaceuticals Inc. - Common Stock | $10.906.500 | 0,49% | 1.650.000 | $-597.896 | Naik ×2 | ||
| VERA Vera Therapeutics, Inc. - Class A Common Stock | $10.727.500 | 0,48% | 250.000 | $670.000 | |||
| PRQR ProQR Therapeutics N.V. - Ordinary Shares | $10.311.721 | 0,47% | 5.543.936 | $6.335.791 | Naik ×1 | ||
| NAMS NewAmsterdam Pharma Company N.V. - Ordinary Shares | $9.319.750 | 0,42% | 275.000 | $517.000 | |||
| KRRO Korro Bio, Inc. - Common Stock | $9.316.995 | 0,42% | 706.904 | $1.314.842 | |||
| QURE uniQure N.V. - Ordinary Shares | $9.212.000 | 0,42% | 200.000 | Opsi beli | $4.307.000 | Turun ×2 | |
| AVR Anteris Technologies Global Corp. - Common Stock | $8.987.110 | 0,41% | 912.397 | $3.923.307 | |||
| ZURA Zura Bio Limited - Class A Ordinary shares | $8.639.388 | 0,39% | 1.464.303 | $-6.618.215 | Turun ×1 | ||
| QURE uniQure N.V. - Ordinary Shares | $8.060.500 | 0,36% | 175.000 | ||||
| Penerbit tidak dikenal (CUSIP: K08588103) | $8.001.600 | 0,36% | 30.000 | Naik ×1 | |||
| IBIO iBio, Inc. - Common Stock | $7.013.792 | 0,32% | 4.007.881 | $1.110.112 | Naik ×2 | ||
| Penerbit tidak dikenal (CUSIP: 370920100) | $6.748.000 | 0,30% | 400.000 | $2.373.000 | Naik ×1 | ||
| EVMN Evommune, Inc. Common Stock | $6.646.329 | 0,30% | 500.100 | Opsi jual | Naik ×1 | ||
| TYRA Tyra Biosciences, Inc. - Common Stock | $6.388.383 | 0,29% | 200.012 | $-3.474.327 | Turun ×1 | ||
| SLGL Sol-Gel Technologies Ltd. - Ordinary Shares | $6.294.486 | 0,28% | 84.900 | $3.521.786 | Naik ×1 | ||
| SABS SAB Biotherapeutics, Inc. - Common Stock | $5.947.500 | 0,27% | 1.525.000 | $3.745.250 | Naik ×1 | ||
| MGNX MacroGenics, Inc. - Common Stock | $5.620.720 | 0,25% | 1.216.606 | $4.175.720 | Naik ×2 | ||
| CRSP CRISPR Therapeutics AG - Common Shares | $5.454.000 | 0,25% | 100.000 | $-1.681.500 | Turun ×1 | ||
| NAMSW NewAmsterdam Pharma Company N.V. - Warrant | $5.343.450 | 0,24% | 245.000 | $433.650 | |||
| ASMB Assembly Biosciences, Inc. - Common Stock | $5.221.200 | 0,24% | 190.000 | Naik ×1 | |||
| RZLT Rezolute, Inc. - Common Stock (NV) | $5.200.000 | 0,24% | 1.000.000 | $479.695 | Turun ×2 | ||
| DTIL Precision BioSciences, Inc. - Common Stock | $5.082.087 | 0,23% | 646.576 | $1.793.384 | Naik ×1 | ||
| Penerbit tidak dikenal (CUSIP: 423494103) | $5.069.842 | 0,23% | 138.030 | Naik ×1 | |||
| VRDN Viridian Therapeutics, Inc. - Common Stock | $4.592.500 | 0,21% | 250.000 | $-297.500 | |||
| AVBP ArriVent BioPharma, Inc. - Common Stock | $4.342.500 | 0,20% | 125.000 | $305.250 | Turun ×1 | ||
| VRCA Verrica Pharmaceuticals Inc. - Common Stock | $4.328.909 | 0,20% | 707.338 | $587.091 | |||
| CMPS COMPASS Pathways Plc - American Depository Shares | $4.261.739 | 0,19% | 301.183 | $-1.868.172 | Turun ×1 | ||
| MBX MBX Biosciences, Inc. - Common Stock | $4.140.000 | 0,19% | 75.000 | $-337.500 | Turun ×2 | ||
| Penerbit tidak dikenal (CUSIP: G75226103) | $3.959.000 | 0,18% | 370.000 | Naik ×1 | |||
| IMVT Immunovant, Inc. - Common Stock | $3.853.000 | 0,17% | 100.000 | $1.369.000 | |||
| Penerbit tidak dikenal (CUSIP: G0375M101) | $3.810.000 | 0,17% | 375.000 | Naik ×1 | |||
| BHVN Biohaven Ltd. Common Shares | $3.720.000 | 0,17% | 250.000 | Naik ×1 | |||
| SNSE Sensei Biotherapeutics, Inc. - Common Stock | $3.610.100 | 0,16% | 144.404 | Naik ×1 | |||
| KPTI Karyopharm Therapeutics Inc. - Common Stock | $3.053.125 | 0,14% | 312.500 | $268.125 | Turun ×2 | ||
| ALEC Alector, Inc. - Common Stock | $3.035.100 | 0,14% | 1.510.000 | $1.960.100 | Naik ×1 | ||
| SGP SpyGlass Pharma, Inc. - Common Stock | $2.929.104 | 0,13% | 131.586 | $-3.548.396 | Turun ×1 | ||
| CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | $2.806.500 | 0,13% | 75.000 | $82.500 | |||
| OACCU Oaktree Acquisition Corp. III Life Sciences - Unit | $2.750.000 | 0,12% | 250.000 | $87.500 | |||
| Penerbit tidak dikenal (CUSIP: 15102KAB6) | $2.282.800 | 0,10% | 2.000.000 | Naik ×1 | |||
| Penerbit tidak dikenal (CUSIP: G50765109) | $2.272.000 | 0,10% | 200.000 | Naik ×1 | |||
| NMRA Neumora Therapeutics, Inc. - Common Stock | $1.820.107 | 0,08% | 1.070.651 | Naik ×1 | |||
| AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | $1.778.022 | 0,08% | 98.999 | Naik ×1 | |||
| ANL Adlai Nortye Ltd. - American Depositary Shares | $1.769.241 | 0,08% | 153.847 | $629.185 | Turun ×1 | ||
| Tidak ada hasil | |||||||
Kepemilikan dengan keyakinan
Posisi meningkat selama 3+ kuartal berturut-turut.
Jumlah saham dilaporkan dalam pengajuan 13F (tidak disesuaikan split)
Taruhan baru terbesar
Posisi baru dibuka kuartal ini, terbesar diurutkan pertama.
| Sekuritas | Nilai | Saham | % dari portofolio |
|---|---|---|---|
| Penerbit tidak dikenal (CUSIP: 337185102) | $40.884.081 | 2.032.012 | 1,85% |
| MRNA | $35.015.000 | 500.000 | 1,58% |
| ARKG | $31.545.000 | 750.000 | 1,43% |
| LLY | $23.988.600 | 20.000 | 1,08% |
| IDYA | $14.908.000 | 400.000 | 0,67% |
| Penerbit tidak dikenal (CUSIP: 67613T104) | $14.338.334 | 766.346 | 0,65% |
| OMER | $13.421.463 | 1.411.300 | 0,61% |
| ALKS | $13.098.750 | 250.000 | 0,59% |
| QURE | $8.060.500 | 175.000 | 0,36% |
| Penerbit tidak dikenal (CUSIP: K08588103) | $8.001.600 | 30.000 | 0,36% |
| EVMN | $6.646.329 | 500.100 | 0,30% |
| ASMB | $5.221.200 | 190.000 | 0,24% |
| Penerbit tidak dikenal (CUSIP: 423494103) | $5.069.842 | 138.030 | 0,23% |
| Penerbit tidak dikenal (CUSIP: G75226103) | $3.959.000 | 370.000 | 0,18% |
| Penerbit tidak dikenal (CUSIP: G0375M101) | $3.810.000 | 375.000 | 0,17% |
Penggerak teratas (QoQ)
| Sekuritas | Aksi | Saham Δ | Nilai Δ |
|---|---|---|---|
| ROIV | Beli lebih banyak | +950K | +$55.2M |
| SYRE | Hanya pergerakan harga | +0 | +$49.0M |
| RVMD | Beli lebih banyak | +150K | +$37.1M |
| AVTX | Beli lebih banyak | +1.6M | +$33.6M |
| ORKA | Beli lebih banyak | +90K | +$31.6M |
| TEVA | Dipangkas | -1.0M | -$29.5M |
| APGE | Dipangkas | -298K | +$22.9M |
| RLAY | Beli lebih banyak | +650K | +$15.7M |
| BLTE | Beli lebih banyak | +100K | +$15.0M |
| SGMT | Beli lebih banyak | +1.6M | +$14.8M |
Posisi yang keluar
Termasuk peristiwa perusahaan (merger, delisting) — tidak semua keluar adalah penjualan
Posisi tertutup mencerminkan perubahan pelaporan 13F; bagi manajer indeks, ini sering kali mekanis (penghapusan pencatatan, M&A, penyeimbangan ulang indeks), bukan keputusan aktif.
| Sekuritas | Kuartal | Saham sebelumnya | Nilai sebelumnya | Harga sejak keluar |
|---|---|---|---|---|
| SPY | 30 Juni 2025 | 430.000 | $240.537.700 | Tidak lagi dilacak |
| XBI | 31 Maret 2026 | 1.500.000 | $182.895.000 | Tidak lagi dilacak |
| SPY | 30 Juni 2026 | 200.000 | $130.068.000 | Tidak lagi dilacak |
| IBB | 31 Maret 2026 | 400.000 | $67.508.000 | 26,2% |
| VRNA | 31 Des. 2025 | 625.000 | $66.693.750 | Tidak lagi dilacak |
| IWM | 30 Juni 2025 | 300.000 | $59.847.000 | Tidak lagi dilacak |
| VTYX | 31 Maret 2026 | 6.484.558 | $58.555.559 | Tidak lagi dilacak |
| SPY | 31 Des. 2025 | 84.490 | $56.285.548 | Tidak lagi dilacak |
| CNTA | 30 Juni 2026 | 1.400.000 | $55.608.000 | Tidak lagi dilacak |
| AMGN | 31 Maret 2026 | 145.000 | $47.459.950 | 24,8% |
| ACLX | 30 Juni 2026 | 362.764 | $41.652.562 | Tidak lagi dilacak |
| XBI | 30 Juni 2025 | 500.000 | $40.550.000 | Tidak lagi dilacak |
| XLV | 31 Maret 2026 | 250.000 | $38.700.000 | Tidak lagi dilacak |
| BPMC | 30 Sep. 2025 | 250.000 | $32.045.000 | Tidak lagi dilacak |
| TERN | 30 Juni 2026 | 562.631 | $29.661.906 | Tidak lagi dilacak |
| MRUS | 31 Des. 2025 | 285.769 | $26.905.151 | Tidak lagi dilacak |
| PTGX | 30 Sep. 2025 | 440.000 | $24.318.800 | 137,4% |
| ASND | 30 Juni 2026 | 95.000 | $21.729.350 | -4,0% |
| EXEL | 31 Des. 2025 | 500.000 | $20.650.000 | 23,8% |
| BMY | 30 Juni 2026 | 300.000 | $18.195.000 | 18,0% |
| MESO | 31 Maret 2025 | 838.600 | $16.604.280 | 35,6% |
| ALNY | 30 Juni 2025 | 55.000 | $14.851.100 | -26,4% |
| SLNO | 31 Des. 2025 | 200.000 | $13.520.000 | Tidak lagi dilacak |
| ARVN | 31 Maret 2025 | 630.000 | $12.077.100 | 36,6% |
| AMGN | 30 Sep. 2025 | 40.000 | $11.168.400 | 55,6% |
| BBIO | 30 Juni 2026 | 150.000 | $11.139.000 | 13,7% |
| WVE | 30 Juni 2026 | 1.401.727 | $10.162.521 | -6,5% |
| CRSP | 30 Sep. 2025 | 200.000 | $9.728.000 | -12,3% |
| IBRX | 30 Juni 2026 | 1.250.000 | $9.587.500 | -8,2% |
| TNGX | 31 Maret 2026 | 1.000.000 | $8.860.000 | 24,6% |
| ELVN | 30 Sep. 2025 | 400.000 | $8.024.000 | 188,1% |
| CORT | 30 Juni 2025 | 70.000 | $7.995.400 | 63,5% |
| TARS | 31 Des. 2025 | 125.000 | $7.428.750 | -11,5% |
| IMVT | 30 Juni 2025 | 430.000 | $7.348.700 | 181,0% |
| RCUS | 31 Maret 2026 | 300.000 | $7.149.000 | 43,0% |
| INZY | 30 Sep. 2025 | 1.749.359 | $6.997.436 | Tidak lagi dilacak |
| AKBA | 31 Des. 2025 | 2.450.000 | $6.688.500 | -45,6% |
| MNPR | 31 Des. 2025 | 79.483 | $6.491.377 | 80,2% |
| NVO | 30 Juni 2026 | 175.000 | $6.431.250 | -2,1% |
| SMMT | 31 Maret 2026 | 350.000 | $6.121.500 | -31,6% |
| ARWR | 31 Maret 2025 | 300.000 | $5.640.000 | 596,3% |
| NBIX | 30 Juni 2025 | 50.000 | $5.530.000 | 23,7% |
| AVDL | 31 Maret 2026 | 250.000 | $5.387.500 | Tidak lagi dilacak |
| AXSM | 30 Sep. 2025 | 50.000 | $5.219.500 | 81,4% |
| NTLA | 31 Des. 2025 | 300.000 | $5.181.000 | 39,1% |
| NMRA | 31 Maret 2025 | 475.000 | $5.035.000 | 66,0% |
| OLMA | 31 Des. 2025 | 500.000 | $4.895.000 | -55,6% |
| OMER | 31 Des. 2025 | 1.133.900 | $4.648.990 | 2,7% |
| PCVX | 31 Des. 2025 | 125.000 | $4.502.500 | 34,9% |
| EWTX | 30 Juni 2025 | 200.000 | $4.400.000 | 252,5% |
| ENGN | 30 Juni 2026 | 610.370 | $4.156.620 | 1,2% |
| SAVA | 31 Maret 2025 | 1.739.400 | $4.104.984 | Tidak lagi dilacak |
| CGON | 30 Juni 2026 | 60.000 | $4.060.800 | 10,5% |
| INSP | 31 Des. 2025 | 50.000 | $3.710.000 | -35,2% |
| SLNO | 30 Juni 2025 | 50.000 | $3.572.500 | Tidak lagi dilacak |
| CELC | 30 Juni 2026 | 30.000 | $3.424.200 | -9,3% |
| JAZZ | 31 Des. 2025 | 25.000 | $3.295.000 | 50,0% |
| CMPS | 31 Maret 2025 | 850.512 | $3.214.935 | 387,4% |
| IBRX | 30 Juni 2025 | 1.025.000 | $3.085.250 | 204,5% |
| MRSN | 31 Maret 2026 | 100.000 | $2.893.000 | Tidak lagi dilacak |
| CGON | 31 Maret 2025 | 100.000 | $2.868.000 | 220,5% |
| AUTL | 31 Des. 2025 | 1.750.000 | $2.852.500 | 21,9% |
| OCUL | 31 Des. 2025 | 239.000 | $2.793.910 | -5,8% |
| CMPX | 30 Juni 2025 | 1.461.507 | $2.776.863 | -4,4% |
| MAZE | 30 Juni 2025 | 250.000 | $2.752.500 | 142,5% |
| KYMR | 30 Juni 2025 | 100.000 | $2.737.000 | 184,4% |
| TECX | 31 Maret 2025 | 58.331 | $2.693.142 | 106,4% |
| HLXB | 31 Maret 2025 | 250.000 | $2.625.000 | Tidak lagi dilacak |
| ABUS | 31 Maret 2026 | 521.900 | $2.510.339 | 11,3% |
| RAPP | 30 Sep. 2025 | 199.643 | $2.269.941 | 66,0% |
| ATXS | 31 Des. 2025 | 300.000 | $2.184.000 | Tidak lagi dilacak |
| UTHR | 31 Des. 2025 | 5.000 | $2.096.050 | 9,5% |
| CORT | 30 Juni 2026 | 50.000 | $2.015.500 | 38,0% |
| THRD | 30 Sep. 2025 | 370.000 | $2.009.100 | Tidak lagi dilacak |
| AVTE | 30 Juni 2025 | 800.000 | $2.008.000 | Tidak lagi dilacak |
| GERN | 31 Maret 2026 | 1.500.000 | $1.980.000 | 5,7% |
| CAPR | 30 Sep. 2025 | 175.000 | $1.737.750 | 6,8% |
| RARE | 31 Maret 2026 | 75.000 | $1.725.000 | 26,0% |
| KZR | 30 Juni 2026 | 229.076 | $1.699.744 | Tidak lagi dilacak |
| APLS | 31 Maret 2025 | 50.000 | $1.595.500 | Tidak lagi dilacak |
| RAPT | 31 Maret 2025 | 1.000.000 | $1.580.000 | Tidak lagi dilacak |
| NVAX | 30 Sep. 2025 | 250.000 | $1.575.000 | -1,5% |
| TRML | 30 Juni 2025 | 100.000 | $1.521.000 | Tidak lagi dilacak |
| ATYR | 31 Des. 2025 | 2.100.000 | $1.514.940 | -32,6% |
| MIST | 31 Des. 2025 | 666.666 | $1.333.332 | -46,0% |
| NKTX | 30 Sep. 2025 | 800.000 | $1.328.000 | 22,3% |
| MBX | 30 Juni 2025 | 175.000 | $1.291.500 | 484,8% |
| NARI | 31 Maret 2025 | 25.000 | $1.276.250 | Tidak lagi dilacak |
| ETNB | 30 Juni 2025 | 175.000 | $1.272.250 | Tidak lagi dilacak |
| SVRA | 31 Maret 2025 | 410.586 | $1.260.499 | 97,1% |
| MIRM | 30 Sep. 2025 | 24.692 | $1.256.576 | 39,8% |
| MGTX | 30 Juni 2025 | 150.000 | $1.017.000 | 119,3% |
| KZR | 31 Maret 2025 | 142.316 | $956.364 | Tidak lagi dilacak |
| OKUR | 30 Sep. 2025 | 347.990 | $831.696 | 58,2% |
| INMB | 30 Sep. 2025 | 354.000 | $817.740 | 4,8% |
| ALT | 30 Sep. 2025 | 200.000 | $774.000 | -20,0% |
| PCSC | 31 Maret 2026 | 50.000 | $651.500 | Tidak lagi dilacak |
| VKTX | 30 Juni 2025 | 25.000 | $603.750 | 30,3% |
| BMEA | 31 Maret 2025 | 150.000 | $582.000 | -35,2% |
| GALT | 30 Sep. 2025 | 250.000 | $527.500 | -13,4% |
| CNTX | 31 Des. 2025 | 402.653 | $390.090 | -68,0% |
| SYRS | 31 Maret 2025 | 1.691.200 | $388.638 | Tidak lagi dilacak |
| BDTX | 30 Juni 2025 | 250.000 | $387.500 | -11,7% |
| RPTX | 31 Des. 2025 | 200.000 | $352.000 | Tidak lagi dilacak |
| CLDX | 31 Maret 2025 | 9.992 | $252.498 | 131,2% |
| CBIO | 31 Des. 2025 | 17.998 | $213.996 | 46,7% |
| RADX | 30 Sep. 2025 | 35.635 | $166.059 | -50,9% |
| ALLK | 30 Juni 2025 | 250.000 | $56.900 | Tidak lagi dilacak |
| SPRY | 31 Des. 2025 | 2.500 | $25.125 | -43,9% |
| IMTXW | 30 Sep. 2025 | 187.204 | $112 | Tidak lagi dilacak |